Skip to Main Content

Paper Details

PARP Inhibition Suppresses GR-MYCN-CDK5-RB1-E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer.
Clin Cancer Res
44
2019
Author NameAffiliation
Ganiraju C ManyamThe University of Texas MD Anderson Cancer Center
Michael SigourosWeill Cornell Medical College
Andrea SbonerEnglander Institute for Precision Medicine, Weill Cornell Medical College and New York Presbyterian Hospital
Andrea SbonerInstitute for Computational Biomedicine, Weill Cornell Medical College
Andrea SbonerWeill Cornell Medical College
Andrea SbonerEnglander Institute for Precision Medicine, Weill Cornell Medical College and New York Presbyterian Hospital
Andrea SbonerWeill Cornell Medical College
Andrea SbonerInstitute for Computational Biomedicine, Weill Cornell Medical College
Himisha BeltranDana Farber Cancer Institute, Harvard Medical School
Himisha BeltranDana Farber Cancer Institute, Harvard Medical School
Yu ChenWeill Cornell Medical College
Yu ChenMemorial Sloan Kettering Cancer Center
Yu ChenMemorial Sloan Kettering Cancer Center
  • 1 - 13

Datasets